White Paper: Role of the autophagy regulator Rubicon in the pathogenesis of fatty liver disease
In 2016, Dr. Tanaka, Dr. Yoshimori, and their colleagues clarified that increased expression of Rubicon in liver causes fatty liver. This was the first report to demonstrate fatty liver is caused by suppression of autophagy in an acquired environment. In this white paper, they describe details of correlation between Rubicon and fatty liver disease
Related Blogs:
- Mechanisms and detection methods of p62/SQSTM1 and its importance in the autophagy pathway.
- Why Autophagy research won a Nobel Prize
- Autophagy Watch
- The ABC’s of LC3
- What do mitochondria have to do with mitophagy?
- Keima-Red for mitophagy detection in living cells
Caltag Medsystems is the UK & Ireland distributor for MBL International. For more information please contact:T: +44 (0)1280 827460 | E: techsupport@caltagmedsystems.co.uk
White Paper: Role of the autophagy regulator Rubicon in the pathogenesis of fatty liver disease